Viewing StudyNCT05020249



Ignite Creation Date: 2024-05-06 @ 4:33 PM
Last Modification Date: 2024-10-26 @ 2:12 PM
Study NCT ID: NCT05020249
Status: COMPLETED
Last Update Posted: 2024-03-22
First Post: 2021-08-20

Brief Title: A Study to Evaluate the Efficacy and Safety of Bimekizumab in Adult Korean Study Participants With Moderate to Severe Plaque Psoriasis
Sponsor: UCB Biopharma SRL
Organization: UCB Pharma

Conditions & Keywords Data

Conditions:
Name
Moderate to Severe Plaque Psoriasis
Keywords:
Name View
Moderate to Severe Plaque Psoriasis View
Korean Study Participants View
BKZ View
UCB4940 View